Optimizing preoperative lung function

Current Opinion in Anaesthesiology

Volumn 14, Issue 1, 2001, Pages 65-69

  Behr, J ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL VENTILATION; ATELECTASIS; BRONCHOSPASM; CHRONIC LUNG DISEASE; CLINICAL FEATURE; EXERCISE; LUNG FUNCTION; LUNG FUNCTION TEST; LUNG RESECTION; NUTRITION; OBSTRUCTIVE AIRWAY DISEASE; PHYSICAL EXAMINATION; PNEUMONIA; POSTOPERATIVE CARE; PRACTICE GUIDELINE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RESPIRATORY FAILURE; REVIEW; SLEEP APNEA SYNDROME; SMOKING CESSATION;

EID: 0035150662     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001503-200102000-00011     Document Type: Review

References (58)

1. Incidence and hospital stay for cardiac and pulmonary complications after abdominal surgery
2. Risk of pulmonary complications after elective abdominal surgery
3. Preoperative pulmonary evaluation
4. Evidence-based preoperative evaluation of candidates for thoracotomy
5. Assessing and modifying the risk of postoperative pulmonary complications
6. Preoperative assessment for pulmonary resection
7. Preventing postoperative pulmonary complications. The role of the anesthesiologist
8. Preoperative pulmonary function and complications after cardiovascular surgery
9. Predicting postoperative pulmonary complications: Is it a real problem?
10. Postoperative complications after thoracic and major abdominal surgery in patients with and without obstructive lung disease
11. Airway obstruction and perioperative complications in smokers undergoing abdominal surgery
12. Factors associated with postoperative pulmonary complications in patients with severe chronic obstructive pulmonary disease
13. Cardiopulmonary exercise testing as a screening test for perioperative management of major surgery in the elderly
14. Preoperative pulmonary function tests do not predict outcome after coronary artery bypass
15. Prospective evaluation of an algorithm for the functional assessment of lung resection candidates
16. Tidal flow-volume analysis of ventilation during exercise
17. Advances in pulmonary laboratory testing
18. Tobacco smoking and pulmonary complications after surgery
19. Role of preoperative cessation of smoking and other factors in postoperative pulmonary complications: A blinded prospective study of coronary artery bypass patients
20. Preoperative smoking habits and postoperative pulmonary complications
21. Effects of weight loss on body composition and pulmonary function
22. The risk of surgery in obese patients
23. Comparison of laparoscopic cholecystectomy in obese and non-obese patients
24. The impact of nutritional status on the outcome of lung volume reduction surgery
25. The effectiveness of incentive spirometry with physical therapy for high-risk patients after coronary artery bypass surgery
26. The effect of incentive spirometry and inspiratory muscle training on pulmonary function after lung resection
27. Incentive spirometry performance
28. Incentive spirometry does not enhance recovery after thoracic surgery
29. The effect of respiratory therapist-initiated treatment protocols on patient outcomes and resource utilization
30. Benefits of a multidisciplinary pulmonary rehabilitation program
31. Pulmonary rehabilitation and surgery for end-stage lung disease
32. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease
33. Optimal assessment and management of chronic obstructive pulmonary disease (COPD): The European Respiratory Society Task Force
34. BTS guidelines for the management of chronic obstructive pulmonary disease
35. Suboptimal medical therapy in COPD
36. Preoperative pulmonary preparation of patients with chronic obstructive pulmonary disease
37. The importance of spirometry in COPD and asthma. Effect on approach to management
38. Assessment of bronchodilator efficacy in symptomatic COPD. Is spirometry useful?
39. An evaluation of salmeterol in the treatment of chronic obstructive pulmonary disease (COPD)
40. Salmeterol reduces dyspnea and improves lung function in patients with COPD
41. Efficacy of salmeterol xinafoate in the treatment of COPD
42. Long acting β2 agonists and theophylline in stable chronic obstructive pulmonary disease
43. Long-acting bronchodilation with once-daily dosing of tiotropium (Spiriva) in stable chronic obstructive pulmonary disease
44. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease
45. Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking
46. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: The ISOLDE trial
47. Anesthetic considerations for patients with severe emphysematous lung disease
48. Chronic obstructive pulmonary disease
49. Do bacteria cause exacerbations of COPD?
50. The role of bacteria in exacerbations of COPD. A constructive view
51. Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD
52. A study of complications related to anesthesia in asthmatic patients
53. Perioperative respiratory complications in patients with asthma
54. A randomized, placebo-controlled study to evaluate the role of salmeterol in the in-hospital management of asthma
55. Minimal complications in a surgical population with severe asthma receiving prophylacytic corticosteroids
56. Low complication rate of corticosteroid-treated asthmatics undergoing surgical procedures
57. Enhancement of postoperative desaturation in heavy snorers
58. Nasal continuous positive airway pressure in the perioperative management of patients with obstructive sleep apnea submitted to surgery